Diabetes in Australia and Vitamin D deficiency. Is there a link?
Literature review
Russell Setright
CVD and Diabetes
Recent research has found significant association between
low serum levels of 25(OH)vit D and an increase in the incidence of diabetes,
CVD and metabolic syndrome. This research examined 28 studies that included
99,745 men and women across a variety of ethnic groups. The studies revealed a
significant association between high levels of vitamin D (25(OH)VitD) and a
decreased risk of developing cardiovascular disease (33% compared to low levels
of vitamin D), type 2 diabetes (55% reduction) and metabolic syndrome (51%
reduction) ( Levels of vitamin D and
cardiometabolic disorders: Systematic review and meta-analysis J.Maturitas
Volume 65, Issue 3, 225-236, March 2010).
Further evidence relating to the befits of adequate vitamin
D levels was presented at the American College of Cardiology’s annual
scientific session in Atlanta March 2010. Researchers from the Intermountain
Medical Center Heart Institute in Murray, Utah, reviewed 31,000 of their
patients aged 50 or older found that those with the lowest levels of serum
25(OH)vitD had a 170-per-cent greater risk of heart attacks than those with the
highest serum levels.
Also, according to the authors of this study, the benefits
of having more vitamin D were not limited to a cut in heart-attack risk. Those
with the lowest readings also had an 80-per-cent greater risk of death, a
54-per-cent higher risk of diabetes, a 40-per-cent higher risk of coronary
artery disease, a 72-per-cent higher risk of kidney failure and a 26-per-cent
higher risk of depression.
Diabetes
The incidence of diabetes in Australia is increasing and, at
the same time we are seeing a corresponding deficiency in vitamin D levels. As
the above studies show there is a strong link between the development of
diabetes type-2 and vitamin D deficiency. The following study examines the link
in childhood type-1 diabetes and vitamin D supplementation.
A review and meta-analysis of the data from five trials that
included 6455 infants, of which 1429 were cases and 5026 controls was published
in the Archives of Disease in Childhood. The data from the five observational
studies, found that infants who received vitamin D supplements were 29 per cent
less likely to develop type-1 diabetes than non-supplemented infants (Zipitis C
et al. "Vitamin D supplementation in early childhood and risk of type 1
diabetes: a systematic review and meta-analysis" Archives of Disease in
Childhood (British Medical Journal) .2007).
Also, a study, published in the Journal of the American
Medical Association, September 2007 looked at 1770 children at high risk of
developing type-1 diabetes.
Their study reported that an increased intake of omega-3
fatty acids from marine sources may reduce a child's risk of developing type-1
diabetes by 55 per cent.Vitamin D found in cod liver oil, a popular marine
supplement, may have been a contributing factor.
Cardio Vascular Disease
Results of a large case-control study (Health Professionals
Follow-up Study) was conducted in 18, 225 men. During the proceeding 10 years
of follow-up, 454 men developed nonfatal myocardial infarction or fatal
coronary heart disease. After adjustment for matched variables, men deficient
in 25(OH)D less than 37.4nmol/Lt were at increased risk for MI (heart attack)
compared with those considered to be sufficient in 25(OH)D 74nmol/mL. And, after additional adjustment for family
history of myocardial infarction, body mass index, physical activity, alcohol
consumption, history of diabetes mellitus and hypertension, ethnicity, region,
marine n-3 intake, low- and high-density lipoprotein cholesterol levels, and
triglyceride levels, this relationship remained significant.
Even men with intermediate 25(OH)D levels were at elevated
risk relative to those with sufficient 25(OH)D levels .
The authors concluded that Low levels of 25(OH)D are
associated with higher risk of myocardial infarction, even after controlling
for factors known to be associated with coronary artery disease (Giovannucci,
E. et al. 25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men, Arch
Intern Med. 2008;168(11):1174-1180).
These benefits in part may be explained by maintaining
optimal vitamin D can slow the turnover of leukocytes by inhibiting
pro-inflammatory overreaction resulting in a reduction of leukocyte telomere
shortening. Shortening of leukocyte telomeres is a marker of aging and a
predictor of aging-related disease. Length of these telomeres decreases with
each cell division and with increased inflammation.
A study that examined
whether vitamin D levels would attenuate the rate of telomere attrition in
leukocytes, such that higher vitamin D concentrations would be associated with
longer LTL. The results of this study suggested that higher vitamin D
(25(OH)VitD) concentrations, which can be modified through vitamin D supplementation, are associated with longer
LTL, would explain the potentially beneficial effects of vitamin D on aging and
age-related diseases.
(Richards J, et al.
Higher serum vitamin D concentrations are associated with longer
leukocyte telomere length in women, American Journal of Clinical Nutrition,
Vol. 86, No. 5, 1420-1425, November 2007)
Discussion
Although I have only included a few of the many studies that
were evaluated, the message is consistent and clear in all of the studies. Vitamin D deficiency is a major health issue
and must be addressed.
Excessive sun exposure causes skin damage and in an
endeavour to curb the incidence of skin cancer, the advice to cover up, apply
sun screen and keep out of the sun is widely being practised. OH&S
legislation has made this policy mandatory for workplace and schools.
However, this practise has in part contributed to the
vitamin D dilemma in Australia and diseases associated with this deficiency,
including melanoma are on the increase and of major concern.
Governments and Health Care Professionals urgently need to
examine the role that vitamin D deficiency plays in their disease treatment and
prevention plans and consider supplementation and dietary changes as an
effective alternative to dangerous sun exposure practises.
Also, periodic 25(OH)VitD blood tests would be advisable.
I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
ReplyDeleteliver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
treatment! This treatment is a breakthrough for all HBV carriers.